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Abstract
Background: Quality of life (QoL) measurements are important in evaluating cancer treatment outcomes.
Factors other than cancer and its treatment may have significant effects on QoL and affect assessment of
treatments. Baseline data from longitudinal studies of women with endometrial or ovarian cancer or adnexal mass
determined at surgery to be benign were analyzed to determine the degree to which QoL is affected by baseline
differences in demographic variables and health.
Methods: This study examined the effect of independent variables on domains of the Functional Assessment of
Cancer Therapy (FACT-G) pre-operatively in gynecologic oncology patients undergoing surgery for pelvic mass
suspected to be malignant or endometrial cancer. Patients also completed the Short Form Medical Outcomes
Survey (SF-36) questionnaire (a generic health questionnaire that measures physical and mental health).
Independent variables were surgical diagnosis (ovarian or endometrial cancer, benign mass), age, body mass index
(BMI), educational level, marital status, smoking status, physical (PCS) and mental (MCS) summary scores of the
SF-36. Multiple regression analysis was used to determine the influence of these variables on FACT-G domain
scores (physical, functional, social and emotional well-being).
Results: Data were collected on 157 women at their pre-operative visit (33 ovarian cancer, 45 endometrial
cancer, 79 determined at surgery to be benign). Mean scores on the FACT-G subscales and SF-36 summary scores
did not differ as a function of surgical diagnosis. PCS, MCS, age, and educational level were positively correlated
with physical well-being, while increasing BMI was negatively correlated. Functional well-being was positively
correlated with PCS and MCS and negatively correlated with BMI. Social well-being was positively correlated with
MCS and negatively correlated with BMI and educational level. PCS, MCS and age were positively correlated with
emotional well-being. Models that included PCS and MCS accounted for 30 to 44% of the variability in baseline
physical, emotional, and functional well-being on the FACT-G.
Conclusion: At the time of diagnosis and treatment, patients' QoL is affected by inherent characteristics.
Assessment of treatment outcome should take into account the effect of these independent variables. As
treatment options become more complex, these variables are likely to be of increasing importance in evaluating
treatment effects on QoL.
Published: 17 May 2007
Health and Quality of Life Outcomes 2007, 5:25 doi:10.1186/1477-7525-5-25
Received: 7 December 2006
Accepted: 17 May 2007
This article is available from: http://www.hqlo.com/content/5/1/25
© 2007 Gil et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Health and Quality of Life Outcomes 2007, 5:25 http://www.hqlo.com/content/5/1/25
Page 2 of 7
(page number not for citation purposes)
Background
Women diagnosed with gynecologic cancer are at risk for
depression, anxiety and reduced quality of life (QoL) [1-
4]. QoL is an important component of assessing the
effects of surgery, radiation, and chemotherapy [5]. In
addition to clinical variables, QoL in cancer patients
undergoing treatment is affected by demographic varia-
bles, socio-economic status, social characteristics and per-
sonal expectations [6,7]. Pretreatment factors have been
found to influence QoL in patients undergoing radiation
therapy [8]. Significant differences in QoL were found as
a function of age, race, Karnofsky Performance Status
(KPS), income level and employment status [8]. Pretreat-
ment Functional Assessment of Cancer Therapy (FACT-G)
scores were higher in patients who were older, white, had
higher KPS scores, were married, had a higher income and
were college graduates. Gender and primary site of disease
did not have an effect. Arredondo et al. examined QoL in
men with prostate cancer and found men with more
comorbidities had significantly worse scores at baseline in
the physical domains [9].
Pretreatment characteristics may affect patients' reaction
to their illness and treatment and thus influence disease
specific QoL scores measured during treatment. The role
these baseline characteristics play in women's ability to
maintain good QoL following diagnosis and during treat-
ment may therefore affect assessment of treatment and
become a factor in determining which treatments are
selected. A health status questionnaire was used to capture
the effect of general physical and mental health as exten-
sive personal information was not available on these
women. The SF-36 was selected as it provides a measure of
the health burden of chronic disease and other medical
conditions that the women may have [10]. Baseline, pre-
operative, data from longitudinal studies of women with
endometrial or ovarian cancer [11,12] were analyzed to
determine the degree to which QoL, measured with a dis-
ease specific questionnaire, is affected by baseline differ-
ences in demographic variables, and physical and mental
health measured with the SF-36. At the time these data
were obtained, women were unaware of their ultimate
diagnosis and/or stage of disease. Women with an adnexal
mass determined at surgery to be benign were included to
control for the effect of cancer.
Methods
This prospective study was conducted at two gynecologic
oncology offices located in Northeastern Ohio. Consecu-
tive patients requiring surgery for a pelvic mass or a posi-
tive endometrial biopsy (endometrial cancer) were
enrolled in a longitudinal assessment of QoL study at
their pre-operative visit between January 2001 and July
2004.
Questionnaires (described below) were completed at the
initial office visit following informed consent to partici-
pate in this IRB approved study. Baseline demographics
were ascertained by interview with a research assistant.
Private office records were reviewed to obtain height,
weight and diagnosis following surgery. Body mass index
(BMI) was calculated (defined as weight (kg) divided by
height (m2) for each woman) and categorized as normal
weight (18.5–24.9), overweight (25–29.9) or obese (BMI
≥ 30) [13]. Smoking was quantified in pack years, a
method used to measure the amount a person has
smoked over a long period of time. It is calculated by mul-
tiplying the number of packs of cigarettes smoked per day
by the number of years the person has smoked [14].
General health status was measured with the Short Form
Medical Outcomes Survey (SF-36), a comprehensive sur-
vey designed to measure physical and mental health [10].
There are 8 subscales, summarized into physical and men-
tal composite scores. Subjects are asked if their health lim-
its activities during a regular day (from vigorous activities
to bathing or dressing), if they have problems with work
or other activities due to physical health or emotional
problems, how they have been feeling emotionally during
the last 4 weeks, if they have pain and how they rate their
health. The SF-36 is a widely used, reliable and validated
instrument with population specific norms that can be
used to evaluate the burden of different diseases and treat-
ments. The questionnaire was used in this study to assess
patients' baseline level of physical and mental health.
QoL was measured with the Functional Assessment of
Cancer Therapy (FACT-G), a 27 item core questionnaire
evaluating physical, functional, social and emotional
well-being within the previous 7 days [15]. While some
questions are similar to those asked on the SF-36, most
questions are specific to cancer and its treatment. For
example, both instruments ask if the patient has pain, and
if they are full of pep (SF-36) or have a lack of energy
(FACT-G), however, the FACT-G was developed specifi-
cally to include items that are affected by the diagnosis of
cancer and its treatment. Items are summed to give scores
for each domain. All domains are scored so that a higher
score indicates higher QoL [16]. The FACT-G is a reliable
and validated instrument for measuring QoL in cancer
patients, including the elderly [15,16].
In addition to analyzing the four domain scores, five ques-
tions were selected a priori for analysis to determine the
distribution of responses (not at all to very much). Two
questions not directly related to treatment were selected
from the physical well-being domain, and one question
each from the social, emotional and functional well-being
domains. The questions addressed level of energy, pain,
support from family, feeling nervous and ability to enjoyHealth and Quality of Life Outcomes 2007, 5:25 http://www.hqlo.com/content/5/1/25
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life. Prior research in cancer patients has indicated these
areas as problematic [2]. Responses to these questions
were analyzed to determine how many women were
already experiencing difficulties in these clinically rele-
vant areas that are likely to become increasingly impor-
tant during the treatment process.
In this study, touch screen computers with 15 inch moni-
tors were programmed with the FACT-G questionnaire
[17]. Sequential screens are programmed with one
domain per screen; patients complete the questionnaire
by touching responses to each question within the
domain. The physical, social, and functional well-being
screens have 7 questions on the screen; the emotional well
being screen has 6 questions. Patients may change their
answer by touching an alternate response on that screen
but cannot return to a previous screen. Patients completed
the questionnaire on their own, but the research assistant
was available if they had questions. Patients were given
the option of completing the paper version of the ques-
tionnaire, but used the computer the majority of the time
[17]. The effect of using the computer, versus completing
the questionnaires on paper, has been previously
described [17]. Women were found to respond to the con-
tent of the questionnaires and not the method of admin-
istration.
Statistical analysis
Mean QoL (FACT-G) and general health status (SF-36) scores
Scores on the FACT-G subscales and the SF-36 summary
scores were analyzed as a function of diagnosis (ovarian
or endometrial cancer, benign adnexal mass). Outcomes
were not analyzed as a function of stage of disease as the
majority of ovarian cancer patients were stage III/IV and
nearly all endometrial cancer patients were Stage I/II.
Scores on the FACT-G subscales and SF-36 summary
scores were compared with normative data. Differences
greater than 2–3 points were considered clinically impor-
tant for the FACT-G physical and functional subscales and
greater than 2 points for the FACT-G emotional subscale
[16]. Analysis of variance was used to determine if there
were significant differences as a function of diagnosis.
Univariate Analyses
Age, BMI, education and number of pack years smoked
were analyzed as continuous variables and marital status
and diagnosis were analyzed as categorical variables. Mar-
ital status was categorized as being married or non-mar-
ried (single, divorced, and widowed) and differences were
analyzed with the t-test. Pearson correlation coefficients
were calculated for normally distributed continuous vari-
ables (age, BMI), SF-36 physical summary score (PCS)
and mental summary score (MCS) with FACT-G domains.
Spearman's correlation coefficients were calculated for
non normally distributed continuous variables (educa-
tion, pack years smoked) with FACT-G domains.
Multiple regression analysis was used to assess the effect
of PCS and MCS scores, diagnosis, age, BMI, educational
level, marital status, and smoking status on FACT-G
domain scores. For this analysis, educational level was cat-
egorized as < 16 years versus ≥ 16 years (college degree or
higher) and smoking was categorized according to < 5.0
versus ≥ 5.0 pack years. The variables were regressed on
individual FACT-G domains (physical, functional, emo-
tional and social) using a stepwise linear regression proce-
dure. Variables were entered in the regression models at a
probability level of p < 0.05 and were removed at a prob-
ability level > 0.10. Collinearity diagnostics (tolerance
and variance inflation factor) were examined to assess
multi-collinearity of variables included in the final model.
SPSS version 14.0 (Chicago, IL) was used for analysis.
Results
Of the 212 consecutively approached patients, 172 agreed
to participate (81%). Only one of the two questionnaires
was completed by 15 patients and they were excluded
from subsequent analysis (final n = 157).
Fifty percent of the women had a diagnosis of cancer; 73%
were overweight, 36% smoked at some time point, 35%
were college graduates and most were married (Table 1).
The majority of women with ovarian cancer were diag-
nosed with Stage III/IV disease; nearly all women with
endometrial cancer had Stage I or II disease.
Scores from the FACT-G and the SF-36 are presented in
Table 2. There were no significant differences for any of
the FACT-G subscales or the SF-36 summary scores as a
function of diagnosis (all F values less than 1.7; all p val-
ues > 0.19). Normative data for FACT-G subscales from
women with cancer were similar to those from women in
the general population with the exception of social well-
being scores, which were slightly higher in women with
cancer [18]. Scores for patients with ovarian cancer in this
study were within 2 points of normative data for cancer
patients on all the FACT-G subscales. Scores for patients
with endometrial cancer differed by less than 3 points on
the physical well-being subscale and differed by 2 points
or less for the other subscales of the FACT-G relative to
normative data for cancer patients. Physical and func-
tional well-being subscale scores for women with a mass
determined at surgery to be benign were within 2 points
of normative data for women with cancer and women in
the general population. Mean score on the social well-
being subscale of the FACT-G was slightly higher (2.4
points) than normative data from women in the general
population but the same as normative data from women
with cancer. Mean score on the emotional well-being sub-Health and Quality of Life Outcomes 2007, 5:25 http://www.hqlo.com/content/5/1/25
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scale was slightly lower (2.4 points) than normative data
for women in the general population, but within 2 points
of normative data from women with cancer. Patients'
physical and mental composite scores from the SF-36
were within 2 to 3 points of data collected in women from
the US population aged 55–64 [19].
Correlations between the FACT-G domains and clinical
and demographic variables are presented in Table 3. SF36
physical (PCS) and mental health (MCS) scores, age, and
educational level were positively correlated with physical
well-being while increasing BMI was negatively corre-
lated. Functional well-being was positively correlated with
PCS and MCS and negatively correlated with BMI. Social
well-being was positively correlated with MCS, and nega-
tively correlated with BMI and educational level. PCS,
MCS and age were positively correlated with emotional
well-being. There were no differences in mean scores on
the FACT-G subscales between women who were married
or not married and no significant correlations between
number of pack years smoked and subscales on the FACT-
G (data not shown).
PCS and MCS accounted for a significant amount of the
variance (R2) in regression models for each of the FACT-G
domains (Table 4). Models that included physical and
mental health accounted for a significant amount of the
variability in well-being scores. The models accounted for
30 to 44% of the variability in baseline physical, emo-
tional, and functional well-being.
At baseline, there was a range of responses to questions
that addressed issues such as level of energy, pain, emo-
tional support from family, feeling nervous and being
able to enjoy life (Table 5). Approximately half of the
women had been feeling a little bit or somewhat nervous
for the past 7 days (58%) and an additional 26% had been
feeling quite a bit or very nervous. Half of the women
responded a little bit or somewhat when asked if they had
a lack of energy (55%) or pain (48%). Eighty percent of
them responded they were able to enjoy life and received
emotional support from their family quite a bit or very
much.
Discussion
At the time of this initial visit with a gynecologic oncolo-
gist, all women were aware that they would be undergoing
major surgery, either for endometrial cancer or to remove
a pelvic mass. At that time, women did not know their dis-
ease status and/or stage of disease. Mean QoL and general
health scores of women were similar to those of popula-
tion norms from the US general population or from can-
Table 1: Patient demographics, #(%)
Age, mean (SD), range 58.76 (13.6), 26–86 years
Final diagnosis
Ovarian cancer 33 (21%)
Endometrial cancer 45 (29%)
Benign adnexal mass 79 (50%)
Overweight or obese (BMI ≥ 25)
Ovarian cancer 22 (67%)
Endometrial cancer 38 (84%)
Benign adnexal mass 54 (68%)
Smoking
Never 101 (64%)
< 5.0 pack years 10 (6%)
> 5.0 pack years 46 (30%)
College graduate 55 (35%)
Stage of cancer
Ovarian cancer
I/II 12 (36%)
III/IV 21 (64%)
Endometrial cancer
I/II 43 (96%)
III/IV 2 (4%)
Married 91 (58%)Health and Quality of Life Outcomes 2007, 5:25 http://www.hqlo.com/content/5/1/25
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cer patients. Mean social well-being scores for all groups
in this study were similar to population norms for cancer
patients but higher than that for the general population.
This difference has been observed before and may be due
to women seeking social support during this time [18].
Despite the fact that mean scores were similar to reference
standards, there was a range of scores on the QoL survey.
The majority of the women were enjoying life, but approx-
imately half were already reporting a little bit or some-
what lack of energy and pain. Women with better general
physical and mental health had higher physical, func-
tional and emotional well-being scores on a disease spe-
cific QoL instrument. Age was positively correlated with
physical and emotional well-being in univariate and mul-
tivariate analyses. Wan et al examined the relationship
between demographic variables (including age), clinical
factors and social characteristics and measures on the four
subscales of the FACT-G in cancer patients who had com-
pleted a minimum of two cycles of chemotherapy or 10
radiation therapy treatments [7]. They found lower QoL
scores among those with poorer performance status,
younger patients and lower SES. Consistent with their
results, in this study younger age was associated with
lower physical, emotional and total QoL scores. A recent
study of 2208 women with breast cancer who completed
the EORTC general cancer QoL scale (breast cancer mod-
ule) found that younger age was a significant risk factor
for poorer QoL [20]. Movsas et al. speculated that the
observation of decreased QoL in younger patients may be
due to the devastating impact of a cancer diagnosis at a
younger age [8].
Table 2: Mean (SD) quality of life (FACT-G) and general health status (SF-36) scores
Mean SD Normative Data –
Cancer, Female (18)
Normative Data – 
General US Female (18)
Normative Data – 
Women Age 55–64 (19)
Physical, FACT-G (0–28) 23.3 4.6 21.60 22.10
Ovarian cancer 23.3
Endometrial cancer 24.0
Benign adnexal mass 23.0
Functional, FACT-G (0–28) 20.2 4.5 19.50 18.30
Ovarian cancer 19.4
Endometrial cancer 21.5
Benign adnexal mass 19.7
Social, FACT-G (0–28) 22.3 4.6 22.30 19.80
Ovarian cancer 22.8
Endometrial cancer 22.2
Benign adnexal mass 22.2
Emotional, FACT-G (0–24) 17.5 6.2 18.70 19.40
Ovarian cancer 18.5
Endometrial cancer 17.6
Benign adnexal mass 17.0
PCS, SF-36 43.6 11.7 45.03
Ovarian cancer 42.7
Endometrial cancer 45.7
Benign adnexal mass 42.7
MCS, SF-36 49.4 10.6 50.56
Ovarian cancer 51.4
Endometrial cancer 49.0
Benign adnexal mass 48.8
Table 3: Univariate Analyses: Correlations between FACT domains, SF36 (PCS, MCS), demographic variables and smoking status
FACT Domain PCS MCS Age BMI Education
Physical .480*** .430*** .275*** -.191** .191*
Functional .372*** .445*** .125 -.154* .119
Social .103 .184* .016 -.161* -.168*
Emotional .141* .578*** .307*** -.128 .065
*p <.05, ** p < .01, *** p < .001Health and Quality of Life Outcomes 2007, 5:25 http://www.hqlo.com/content/5/1/25
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Higher BMI was negatively correlated with physical and
functional well-being in univariate analyses. Obesity has
not specifically been linked to scores on the FACT-G, how-
ever, it has been linked to lower scores on the SF-36 [21].
In this study, increased BMI did not continue to be signif-
icant in multivariate analyses of physical and functional
well-being when the SF-36 summary scores were
included. BMI continued to be a significant independent
variable included in the model for social well-being.
Weight, BMI, waist and hip circumference and waist-hip-
ratio are all strongly associated with increased risk of
endometrial cancer [22], and obesity is increasing in the
United States [23]. Decreased general health status and
decreased QoL may become increasingly important in
assessing treatment outcomes for women with endome-
trial cancer.
A model that included physical and mental health sum-
mary scores from the SF-36 and age accounted for 44% of
the variability in the total FACT-G scores. This is similar to
the findings by Wan et al. that 45% of the variability in
total FACT-G scores in cancer patients who had under-
gone treatment was accounted for by demographic varia-
bles (age, gender, living arrangement, race/ethnicity, SES),
clinical variables (performance status, disease type and
stage) and social factors (spiritual beliefs, religious affilia-
tion and relationship with physician) [7]. These data sug-
gest that physical and mental health and age are able to
account for a significant amount of the variability in pre-
treatment QoL scores in women undergoing gynecologic
surgery.
The main limitation of this study is the small sample size
and the lack of diversity. The lack of diversity may have
allowed the authors to determine the effect of the inde-
pendent variables on the subscales of the FACT-G but also
limits the generalizability of the results. These results
should be replicated, and expanded, in larger samples of
women.
FACT-G subscale scores did not differ significantly as a
function of diagnostic group (Table 2) and diagnosis was
not a significant variable in the multiple regression mod-
els. None of the women had started treatment for their ill-
ness and all were facing a similar first step. This reinforces
the observation in this study that baseline characteristics
Table 4: Multiple linear regression analysis for each FACT-G domain
FACT domain Variables Standardized Beta coefficient t value p value R, adjusted R2 F value, p value
Physical PCS 0.486 8.06 < 0.01 0.67, 0.44 41.9,
MCS 0.351 5.69 <0.01 p < 0.001
Age 0.244 3.94 <0.01
Functional MCS 0.428 6.44 <0.01 0.57, 0.31 36.4,
PCS 0.351 5.27 <0.01 p < 0.001
Social MCS 0.207 2.64 <0.01 0.31, 0.08 5.4,
College Grad -0.205 -2.61 0.010 p = 0.001
BMI -0.170 -2.19 0.030
Emotional MCS 0.525 8.04 <0.01 0.62, 0.37 31.8,
Age 0.201 3.07 <0.01 p < 0.001
PCS 0.135 2.11 0.037
Total MCS 0.493 7.96 <0.01 0.67, 0.44 41.01,
PCS 0.368 6.06 <0.01 p < 0.001
Age 0.158 2.55 0.01
Table 5: Individual FACT-G questions
Not at all A little bit/Somewhat Quite a bit/Very much
"I have a lack of energy" 37 (24%) 87 (55%) 33 (21%)
"I have pain" 61 (39%) 75 (48%) 31 (20%)
"I get emotional support from my 
family"
9 (6%) 18 (12%) 130 (83%)
"I feel nervous" 25 (16%) 91 (58%) 41 (26%)
"I am able to enjoy life" 3 (2%) 28 (18%) 126 (80%)Publish with BioMed Central    and   every 
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unrelated to disease are already affecting QoL in areas that
will eventually become important for women undergoing
long-term treatment.
Conclusion
Specific aspects of QoL that will be affected by cancer and
treatment are affected by level of education, lifestyle and
general health. Women, at baseline, have a range in level
of physical and emotional health. These baseline charac-
teristics may affect women's ability to tolerate surgery, reg-
imens such as IP chemotherapy, consolidation
chemotherapy and secondary surgical debulking. Further
research should examine whether women beginning the
therapeutic process at a disadvantage have difficulties
completing therapy and whether early interventions
increase later QoL.
Competing interests
The author(s) declare that they have no competing inter-
ests.
Authors' contributions
KG and VVG conceived of the study and design. VVG, HG,
EJ and MH implemented the study and were responsible
for day to day conduct of the study. KG and HG analyzed
the data. KG, HG and VVG drafted the manuscript; EJ and
MH provided critical review. All authors read and
approved the final manuscript.
Acknowledgements
Funding for support of this study was provided by the Irene H. Smith 
Memorial Fund of the Stark Community Foundation, the Akron General 
Development Foundation and the Northeastern Ohio Universities College 
of Medicine Foundation.
References
1. Bodurka-Bevers D, Basen-Engquist K, Carmack CL, Fitzgerald MA,
Wolf JK, de Moor C, Gershenson DM: Depression, anxiety, and
quality of life in patients with epithelial ovarian cancer.  Gyne-
col Oncol 2000, 78:302-308.
2. Miller BE, Pittman B, Strong C: Gynecologic cancer patients' psy-
chosocial needs and their views on the physician's role in
meeting those needs.  Int J Gynecol Cancer 2003, 13:111-119.
3. Kornblith AB, Thaler HT, Wong G, Vlamis V, Lepore JM, Loseth DB,
Hakes T, Hoskins WJ, Portenoy RK: Quality of life of women with
ovarian cancer.  Gynecol Oncol 1995, 59:231-242.
4. Lakusta CM, Atkinson MJ, Robinson J, Nation J, Taenzer PA, Campo
MG: Quality of life in ovarian cancer patients receiving chem-
otherapy.  Gynecol Oncol 2001, 81:490-495.
5. Jones GL, Ledger W, Bonnett TJ, Radley S, Parkinson N, Kennedy SH:
The impact of treatment for gynecological cancer on health-
related quality of life (HRQoL): a systematic review.  Am J
Obstet Gynecol 2006, 194:26-42.
6. Wan GJ, Counte MA, Cella DF: The influence of personal expec-
tations on cancer patients' reports of health-related quality
of life.  Psychooncology 1997, 6:1-11.
7. Wan GJ, Counte MA, Cella DF, Hernandez L, Deasy S, Shiomoto G:
An analysis of the impact of demographic, clinical and social
factors on health related quality of life.  Value Health 1999,
2:308-318.
8. Movsas B, Scott C, Watkins-Bruner D: Pretreatment factors sig-
nificantly influence quality of life in cancer patients: A Radia-
tion Therapy Oncology Group (RTOG) analysis.  Int J Radiat
Oncol Biol Phys 2006, 65:830-835.
9. Arredondo SA, Elkin EP, Marr PL, Latini DM, DuChane J, Litwin MS,
Carroll PR, CaPSURE Investigators: Impact of comorbidity on
health related quality of life in men undergoing radical pros-
tatectomy: Data from CaPSURE.  Urology 2006, 67:559-565.
10. Ware JE Jr, Sherbourne CD: The MOS 36-item short-form
health survey (SF-36). I. Conceptual framework and item
selection.  Med Care 1992, 30:473-483.
11. von Gruenigen VE, Gil KM, Frasure HE, Jenison EL, Hopkins MP: The
impact of obesity and age on quality of life in gynecologic sur-
gery.  Am J Obstet Gynecol 2005, 193:1369-1375.
12. von Gruenigen VE, Frasure HE, Jenison EL, Hopkins MP, Gil KM: Lon-
gitudinal assessment of quality of life and lifestyle in newly
diagnosed ovarian cancer patients: the roles of surgery and
chemotherapy.  Gynecol Oncol 2006, 103:120-126.
13. BMI – Body Mass Index; BMI for adults  Department of Health and
Human Services, Centers for Disease Control and Prevention  [http://
www.cdc.gov/nccdphp/dnpa/bmi/adult_BMI/about_adult_BMI.htm].
Accessed November 7, 2006
14. National Cancer Institute: U.S. National Institutes of Health.
Dictionary of Cancer Terms  [http://www.cancer.gov/dictionary].
Accessed March 10, 2007
15. Cella DF, Tulsky DS, Gray G, Sarafin B, Linn E, Bonomi A, Silberman
M, Yellen SB, Winicour P, Brannon J: The Functional Assessment
of Cancer Therapy scale: development and validation of the
general measure.  J Clin Oncol 1993, 11:570-579.
16. Webster K, Cella D, Yost K: The Functional Assessment of
Chronic Illness Therapy (FACIT) Measurement System:
properties, applications, and interpretation.  Health Qual Life
Outcomes 2003, 1:79.
17. Gil KM, Frasure HE, Hopkins MP, Jenison EL, von Gruenigen VE:
Effect of method administration on longitudinal assessment
of quality of life in gynecologic cancer: an exploratory study.
Health Qual Life Outcomes 2005, 3:6.
18. Brucker PS, Yost K, Cashy J, Webster K, Cella D: General popula-
tion and cancer patient norms for the Functional Assess-
ment of Cancer Therapy – General (FACT-G).  Eval Health Prof
2005, 28:192-211.
19. Ware JE, Snow KK, Kosinski M: SF-36 Health Survey: Manual
and Interpretation Guide.  Lincoln, RI: Quality Metric Incorpo-
rated, 1993; 2000. 
20. Hopwood P, Haviland J, Mills J, Sumo G, Bliss M: The impact of age
and clinical factors on quality of life in early breast cancer: An
analysis of 2208 women recruited to the UK START Trial
(Standardisation of Breast Radiotherapy Trial).  Breast 2007,
16:241-51.
21. Doll HA, Petersen SE, Stewart-Brown SL: Obesity and physical
and emotional well being: associations between body mass
index, chronic illness and the physical and mental compo-
nents of the SF-36 questionnaire.  Obes Res 2000, 8:160-170.
22. Friedenreich C, Cust A, Lahmann PH, et al.: Anthropometric fac-
tors and risk of endometrial cancer: the European prospec-
tive investigation into cancer and nutrition.  Cancer Causes
Control 2007, 18:399-413.
23. Centers for Disease Control and Prevention (CDCL): State-spe-
cific prevalence of obesity among adults–United States,
2005.  MMWR 55:985-8. 2006 Sep 15